The following table shows the list of Horizon 2020 projects developed by "INSTITUT DE RECHERCHES SERVIER". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | IC-3i-PhD | H2020-EU.1.3.4. | partner | 0.00 | 2016-09-01 | 761 |
2 | FRAGNET | H2020-EU.1.3.1. | partner | 0.00 | 2016-03-01 | 928 |
3 | RHAPSODY | H2020-EU.3.1.7. | participant | 0.00 | 2016-04-01 | 711 |
4 | IMPRiND | H2020-EU.3.1.7. | participant | 0.00 | 2017-03-01 | 785 |
5 | EQIPD | H2020-EU.3.1.7. | participant | 0.00 | 2017-10-01 | 799 |
6 | ESCulab | H2020-EU.3.1.7. | participant | 0.00 | 2018-12-01 | 356 |
7 | MELLODDY | H2020-EU.3.1.7. | participant | 0.00 | 2019-06-01 | 409 |
8 | EBiSC2 | H2020-EU.3.1.7. | participant | 0.00 | 2019-03-01 | 375 |
9 | ZENITH | H2020-EU.1.3.1. | partner | 0.00 | 2019-10-01 | 359 |
totale | 0.00 |
This organization collaborated with partners in 16 countries.
Within the project IC-3i-PhD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | FR | SANOFI | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
coordinator | FR | INSTITUT CURIE | INSTITUT CURIE (REC) |
Within the project FRAGNET this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | NL | 24 Media Labs (PRC) | |
partner | UK | IOTA PHARMACEUTICALS LTD | IOTA Pharmaceuticals Ltd (PRC) |
participant | UK | Vernalis | VERNALIS (R&D) LIMITED (PRC) |
coordinator | NL | STICHTING VU | STICHTING VU (HES) |
participant | NL | ZoBio BV | ZOBIO BV (PRC) |
partner | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | SE | BEACTICA AB | BEACTICA THERAPEUTICS AB (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | HU | MTA TTK | TERMESZETTUDOMANYI KUTATOKOZPONT (HES) |
partner | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | UK | UY | UNIVERSITY OF YORK (HES) |
participant | ES | UB | UNIVERSITAT DE BARCELONA (HES) |
Within the project RHAPSODY this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | UPD | UNIVERSITE DE PARIS (HES) |
participant | NL | VUmc | STICHTING VUMC (REC) |
participant | IT | AOU TO | AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO (PUB) |
participant | DE | Lipotype | LIPOTYPE (PRC) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | Sanofi | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
participant | FR | CHRU Lille | CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (HES) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | CH | SCIPROM | SCIPROM SARL (PRC) |
coordinator | CH | UNIL | UNIVERSITE DE LAUSANNE (HES) |
participant | IT | UNIPI | UNIVERSITA DI PISA (HES) |
participant | FR | UPD | UNIVERSITE PARIS DIDEROT - PARIS 7 (HES) |
participant | DE | TUD | TECHNISCHE UNIVERSITAET DRESDEN (HES) |
participant | SE | ULUND | LUNDS UNIVERSITET (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | BE | ULB | UNIVERSITE LIBRE DE BRUXELLES (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
participant | FR | CNRS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC) |
Within the project IMPRiND this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | NERC-BAS | UNITED KINGDOM RESEARCH AND INNOVATION (REC) |
participant | UK | AbbVie | AbbVie Ltd (PRC) |
participant | FR | UBx | UNIVERSITE DE BORDEAUX (HES) |
participant | DE | DZNE | DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV (REC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DE | UMG-GOE | UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS (HES) |
participant | EL | BRFAA | IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON (REC) |
participant | BE | VIB | VIB VZW (REC) |
participant | CH | SCIPROM | SCIPROM SARL (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | DK | Lundbeck | H. LUNDBECK AS (PRC) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UCAM | THE CHANCELLOR MASTERS AND SCHOLARSOF THE UNIVERSITY OF CAMBRIDGE (HES) |
coordinator | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | UK | MRC | MEDICAL RESEARCH COUNCIL (REC) |
participant | DK | AU | AARHUS UNIVERSITET (HES) |
participant | FR | CNRS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC) |
Within the project EQIPD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | BE | Arlenda | PHARMALEX BELGIUM (PRC) |
participant | US | SE | SCIENCE EXCHANGE, INC. (PRC) |
participant | BE | Arlenda | ARLENDA SA (PRC) |
participant | DE | PAASP | PAASP GMBH (PRC) |
participant | NL | ECNP | STICHTING BURO ECNP (OTH) |
participant | US | PGI | PSYCHOGENICS INC (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | US | ABBVIE | ABBVIE INC (PRC) |
participant | FR | Porsolt | PORSOLT SAS (PRC) |
participant | DE | UMC-Mainz | UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAET MAINZ (HES) |
participant | DE | concentris | Concentris Research Management GmbH (PRC) |
participant | UK | Pfizer | PFIZER LIMITED (PRC) |
participant | FR | SARD | SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | NOLDUS | NOLDUS INFORMATION TECHNOLOGY BV (PRC) |
participant | CH | ROCHE | F. HOFFMANN-LA ROCHE AG (PRC) |
participant | NL | Sylics | SYNAPTOLOGICS BV (PRC) |
participant | CH | NOV | NOVARTIS PHARMA AG (PRC) |
participant | FI | ORION | ORION OYJ (PRC) |
participant | UK | UniAbdn | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (HES) |
coordinator | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | CH | UBERN | UNIVERSITAET BERN (HES) |
participant | DE | LMU MUENCHEN | LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN (HES) |
participant | NL | RUG | RIJKSUNIVERSITEIT GRONINGEN (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | NL | RUMC | STICHTING KATHOLIEKE UNIVERSITEIT (HES) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
Within the project ESCulab this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | NL | MTR | MERCATORIAL BV (PRC) |
participant | NL | MLD | MERCALEADS BV (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | BSC | BIOASCENT DISCOVERY LIMITED (PRC) |
participant | NL | PPSC | PIVOT PARK SCREENING CENTRE BV (REC) |
participant | DE | TRS | TAROS CHEMICALS GMBH & CO KG (PRC) |
participant | DE | GRT | GRUNENTHAL GMBH (PRC) |
participant | FR | EDL | EDELRIS SAS (PRC) |
participant | UK | SYG | SYGNATURE DISCOVERY LIMITED (PRC) |
participant | CH | MMV | Medicines for Malaria Venture (REC) |
coordinator | NL | LYG | STICHTING LYGATURE (OTH) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | NL | SCM | SYNCOM BV (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project MELLODDY this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DE | AmgenResMunich | AMGEN RESEARCH (MUNICH) GMBH (PRC) |
participant | FR | Iktos | IKTOS (PRC) |
participant | DE | Loodse GmbH | LOODSE GMBH (PRC) |
participant | FR | SubstraF | SUBSTRA (OTH) |
coordinator | FR | OWKIN | OWKIN FRANCE (PRC) |
participant | DE | Bayer AG | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | CH | NVIDIA SWISS AG | NVIDIA SWITZERLAND AG (PRC) |
participant | NL | Astellas | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | BE | JANSSEN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | CH | NOVARTIS | NOVARTIS PHARMA AG (PRC) |
participant | HU | BME | BUDAPESTI MUSZAKI ES GAZDASAGTUDOMANYI EGYETEM (HES) |
participant | UK | GSK | GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD. (PRC) |
participant | SE | MEDIMMUNE | ASTRAZENECA AB (PRC) |
participant | DE | Merck | MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN (PRC) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
Within the project EBiSC2 this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | FCDI | FUJIFILM CELLULAR DYNAMICS INC (PRC) |
participant | DE | Bayer | BAYER AKTIENGESELLSCHAFT (PRC) |
participant | BE | UCB | UCB BIOPHARMA SRL (PRC) |
participant | UK | Takeda | TAKEDA DEVELOPMENT CENTRE EUROPE LTD (PRC) |
participant | UK | DH | Department of Health (REC) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | UK | PFIZER | PFIZER LIMITED (PRC) |
participant | BE | JAN | JANSSEN PHARMACEUTICA NV (PRC) |
participant | DK | BiP | BIONEER A/S (REC) |
participant | FR | ART | ARTTIC (PRC) |
participant | DK | LUB | H. LUNDBECK AS (PRC) |
participant | DK | NOVO | NOVO NORDISK A/S (PRC) |
coordinator | DE | 01V FHG | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | BE | KU Leuven | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | DE | Charité | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |
Within the project ZENITH this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
partner | FR | OSHA LIANG | OSHA LIANG (PRC) |
participant | FR | USO | SORBONNE UNIVERSITE (HES) |
partner | FR | PHASEVIEW SARL | PHASEVIEW (PRC) |
partner | DE | Intelligent Imaging Innovations GmbH | Intelligent Imaging Innovations GmbH (PRC) |
participant | ES | ZECLINICS SL | ZECLINICS SL (PRC) |
partner | DE | LVBT | LAVISION BIOTEC GMBH (PRC) |
partner | PT | IHMT | UNIVERSIDADE NOVA DE LISBOA (HES) |
participant | PT | FCHAMPALIMAUD | FUNDACAO D. ANNA SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD (REC) |
partner | US | UNIVERSITY OF UTAH | UNIVERSITY OF UTAH (HES) |
coordinator | FR | ICM | INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE (REC) |
partner | US | OFFICE FOR SPONSORED PROGRAMS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (HES) |
partner | UK | Nature Publishing Group | MACMILLAN PUBLISHERS LTD (PRC) |
participant | ES | CNAG-CRG | FUNDACIO CENTRE DE REGULACIO GENOMICA (REC) |
partner | FR | IO | IMAGINE OPTIC (PRC) |
participant | AT | UNIVIE | UNIVERSITAT WIEN (HES) |
partner | ES | UPF | UNIVERSIDAD POMPEU FABRA (HES) |
participant | UK | UEDIN | THE UNIVERSITY OF EDINBURGH (HES) |
participant | UK | UCL | UNIVERSITY COLLEGE LONDON (HES) |
participant | DE | MPG | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV (REC) |
participant | DE | CHARITE | CHARITE - UNIVERSITAETSMEDIZIN BERLIN (HES) |